Serial Number | 79386772 |
Word Mark | PHAROS IBIO |
Filing Date | Wednesday, September 6, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, October 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
NOT AVAILABLE | The non-Latin characters in the mark transliterate to "PHAROS IBIO". |
Goods and Services | Vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; reagents and media for medical and veterinary diagnostic purposes; medicinal healthcare preparations; pharmaceutical drugs; diagnostic agents for pharmaceutical use; medicinal creams; synthetic peptides for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; pharmaceutical compositions; pharmaceuticals; human vaccine preparations; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of immune system related diseases and disorders; nutraceuticals for therapeutic purposes; therapeutic drugs and agents; anti-cancer preparations |
Goods and Services | Scientific research conducted using databases; research and development of vaccines and medicines; analysis in the field of molecular biology; development of computer software for big data processing; research and development of technology for biotechnology; consultancy in the field of biotechnology; research relating to biotechnology; advisory services relating to biotechnology; biotechnology services; biological information check (genetic testing for scientific research purposes); biological information check (genetic testing for medical research purposes); platform as a service [PaaS]; development of cell therapy products; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; research in the field of pharmacogenetics; pharmaceutical research and development; pharmaceutical research services; scientific research in the field of pharmacy; toxicity testing for research purposes; providing technological consultancy relating to design and development of medical diagnostic instruments; providing computer software technical support services in the field of medical diagnostics; medicine research; providing information on the testing, inspection, and research of medical products, consultancy in the field of testing, inspection, and research of medical products; medical and pharmacological research services; scientific research in the fields of medicine, and health and pharmacology; design and development of programs for computers |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 5, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 5, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Pharos iBio Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | KR |
Event Date | Event Description |
Thursday, January 4, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, January 5, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 9, 2024 | APPLICATION FILING RECEIPT MAILED |
Monday, March 18, 2024 | ASSIGNED TO EXAMINER |
Thursday, April 11, 2024 | REFUSAL PROCESSED BY MPU |
Thursday, October 24, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, March 22, 2024 | NON-FINAL ACTION WRITTEN |
Saturday, March 23, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, April 11, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, May 1, 2024 | REFUSAL PROCESSED BY IB |
Thursday, October 24, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Tuesday, June 3, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Tuesday, June 3, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |